Moderna, Pfizer Get Tough Dose Of Medicine
Moderna (NASDAQ:) has experienced a wipeout of nearly 75% in just six months. I’m sure the insiders dumped at just the right time and left the retail bag-holders wondering what just happened with their “investment.”

Pfizer (NYSE:) is actually not doing so hot, either, even though it has shameless taken hundreds of billions of government bucks.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Comments are closed, but trackbacks and pingbacks are open.